SBIR-STTR Award

Novel Composite Dressing for Oxygen Transport in Exudating Wounds
Award last edited on: 2/20/2019

Sponsored Program
SBIR
Awarding Agency
NIH : NIAMS
Total Award Amount
$222,276
Award Phase
1
Solicitation Topic Code
846
Principal Investigator
Joseph C Salamone

Company Information

Rochal Industries LLP

12000 Network Boulevard B200
San Antonio, TX 78249
   (210) 375-9349
   absalamone@aol.com
   www.rochalindustries.com
Location: Single
Congr. District: 20
County: Bexar

Phase I

Contract Number: 1R43AR074783-01
Start Date: 9/12/2018    Completed: 2/28/2019
Phase I year
2018
Phase I Amount
$222,276
Chronic wounds are a significant health problem, cases of which are increasing due to rising numbers of diabetic patients, an upsurge in obesity, an increase in cardiovascular disease, and an aging of the population in the USA, Europe, Japan, and China. Clinical characteristics of chronic wounds are that they are hypoxic (have low oxygen levels), which hinders the healing process, and are moderately to highly exudating. While many types of dressings for chronic wounds are indeed available, the transformative dressing of this proposal addresses a poorly understood key property? driving oxygen into a water-filled (exudating) wound bed, such as that found with most chronic wounds. Water covering the wound bed has low absorption of dissolved oxygen and, hence, poor oxygen transport capability. Water is the rate-limiting step for surface oxygen to penetrate hypoxic tissue. The research of this proposal is being designed to overcome this limitation. The overall goal of this proposal is to commercialize a product that can profoundly improve the wound healing process by transporting oxygen to hypoxic wound tissue while simultaneously removing wound exudate, which typically is rich in degradative proteases and microbial burden (that also hinder wound healing). The specific aims of this proposal include synthesizing oxygen-transporting polymers, mechanically incorporating water absorbing polymers, and testing the resulting materials. Rochal's marketing and sales subsidiary, Atteris Healthcare, will launch the product, if successful, resulting from this research. The Atteris and Rochal teams have determined a wound care market need for a product such as of this proposal ? and are approaching the science in a unique and sound, although risky, manner - to provide ultimately a more conducive environment for wound healing for hypoxic wounds that are nonhealing or difficult to heal.

Project Terms:
absorption; Address; Adhesions; Aging; Atherosclerosis; Automobile Driving; base; Beds; Cardiovascular Diseases; cardiovascular insufficiency; Caring; Characteristics; Chemicals; Chemistry; China; Chronic; chronic wound; Clinical; commercial application; Contact Lenses; design; Development; Diabetes Mellitus; diabetic patient; DM-Et; Elderly; Environment; Epidermis; Europe; Exudate; Film; foot; Goals; healing; Health; Healthcare; high risk; Human; Hydration status; hydrophilicity; Hydrophobicity; Hypertension; Hypoxia; improved; Industry; Investigation; Japan; learning materials; Leg; Liquid substance; Marketing; Mechanics; microbial; Modality; non-healing wounds; novel; Obesity; Ostomy; Oxygen; oxygen transport; Patients; Penetration; Peptide Hydrolases; Permeability; Phase; Pneumonia; Polymers; Population; Process; Property; Research; Research Proposals; Sales; Science; Silicones; sound; Sterile coverings; Surface; technological innovation; Technology; Test Result; Testing; Tissues; Topical application; Transport Process; Ulcer; United States; uptake; Water; wound; Wound Healing;

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----